These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4072368)

  • 1. [Decreased fibrinolytic activity in venous walls of patients with venous thromboses].
    Hach V; Heyland H; Walter-Fincke R; Scharrer I
    Vasa; 1985; 14(4):336-9. PubMed ID: 4072368
    [No Abstract]   [Full Text] [Related]  

  • 2. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M; Hauert J; Bachmann F
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses].
    Hach-Wunderle V; Scharrer I
    Vasa Suppl; 1993; 39():5-10. PubMed ID: 8322122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Actual and reserve fibrinolytic activity in the postoperative period--possibility of exhaustion of the reserve of vascular plasminogen activator].
    Psuja P; Sowier J; Gizło J; Zawilska K
    Acta Haematol Pol; 1980; 11(1):1-7. PubMed ID: 7189316
    [No Abstract]   [Full Text] [Related]  

  • 5. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
    Comp PC; Jacocks RM; Rubenstein C; Radcliffe R
    J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies of the antithrombin III level and plasminogen activator activity in patients with thrombophlebitis].
    Tymiński W; Czestochowska E; Swiecicki P
    Pol Tyg Lek; 1985 Oct; 40(43):1202-4. PubMed ID: 4088936
    [No Abstract]   [Full Text] [Related]  

  • 7. Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis.
    Isacson S; Nilsson IM
    Acta Chir Scand; 1972; 138(4):313-9. PubMed ID: 5040598
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased plasminogen activator but normal prostacyclin activity in rat veins during development of experimental thrombosis.
    Mysliwiec M; Villa S; Kornblihtt L; de Gaetano G; Donati MB
    Thromb Res; 1980 Apr 1-15; 18(1-2):159-65. PubMed ID: 6996209
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
    Conard J; Veuillet-Duval A; Horellou MH; Samama M
    Nouv Rev Fr Hematol (1978); 1982; 24(3):205-9. PubMed ID: 7133990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular component of the fibrinolytic system of blood (plasminogen activator of vascular wall) in patients with duodenal ulcer with a history of hemorrhagic complications].
    Fisher AA; Sakha SK; Kononova VP
    Ter Arkh; 1985; 57(5):137-41. PubMed ID: 4040657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator activity of superficial veins in acute deep venous thrombosis.
    Ljungnér H; Bergqvist D; Isacson S
    Vasa; 1982; 11(3):174-7. PubMed ID: 6890278
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of venous stasis on vessel wall fibrinolysis.
    Stenberg B; Bylock A; Risberg B
    Thromb Haemost; 1984 Apr; 51(2):240-2. PubMed ID: 6539959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disorders in the release of plasminogen activators].
    Brommer EJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):198-207. PubMed ID: 2427402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of the fibrinolysis system].
    Himmelreich G; Riess H
    Dtsch Med Wochenschr; 1991 Mar; 116(11):426-30. PubMed ID: 1900466
    [No Abstract]   [Full Text] [Related]  

  • 16. [Participation of the kidney in changes in the fibrinolytic system during electroshock].
    Andreenko GV; Podorol'skaia LV
    Vopr Med Khim; 1984; 30(4):39-42. PubMed ID: 6542276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered fibrinolysis in DVT: influence of site of sampling.
    Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M
    Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The venous occlusion test in assessing the fibrinolytic activity of the vascular endothelium in lupus nephritis patients].
    Bobkova IN; Poliantseva LR; Tareeva IE; Andreenko GV; Podorol'skaia LV
    Ter Arkh; 1995; 67(4):42-5. PubMed ID: 7784974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical conditioning augments the fibrinolytic response to venous occlusion in healthy adults.
    Williams RS; Logue EE; Lewis JG; Barton T; Stead NW; Wallace AG; Pizzo SV
    N Engl J Med; 1980 May; 302(18):987-91. PubMed ID: 7189244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of plasminogen activator present in the endothelium of venous vessels on the development of thrombotic diseases].
    Czestochowska E
    Pol Tyg Lek; 1974 Apr; 29(14):587-9. PubMed ID: 4828036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.